Download Medical Notes on Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 Medical Notes

About This Presentation

Description:The coronavirus pandemic has been the driving force shaping the biopharma and medtech sectors over the first half of 2020. And, while much of the fallout has been predictable, certain events and trends have surprised. Check out the Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020 for more details

Tags:Pharma, Biotech, Medtech Half-Year Review, 2020 , coronavirus, pandemic

Published on: Jul 30, 2020 | Views : 1759 | Downloads : 0

Comment

Transcript

No transcript available for this presentation

User Presentation
Related Presentations

Generic Drug Program Update

By: MattB
Views: 2188

Evaluate Vantage Report on impact of COVID-19 Biopharma and Medtech

By: MattB
Views: 1209

Evaluate Vantage Pharma, Biotech and Medtech Half-Year Review 2020

By: MattB
Views: 1759

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2019 - Booklet 2

By: MattB
Views: 1367

United Nations Office on Drugs and Crime (UNODC) World Drug Report 2020 - Booklet 5

By: MattB
Views: 1731

Global Medicine Spending and Usage Trends - Outlook to 2024

By: docshare
Views: 1537

Hospital Pharmacy Compliance Handbook

By: anupma
Views: 1242

EvaluatePharma Orphan Drug Report 2020

By: MattB
Views: 1377

Orphan Drugs in the United States - Exclusivity, Pricing and Treated Populations

By: docshare
Views: 1177

Emerging Biopharma’s Contribution to Innovation

By: docshare
Views: 1261

MattB

About : An experienced pharma professional managing sales, marketing and brand management of top global pharma products Presently leading a team of experts in the development and execution of pharma eCommerce strategies that support GSK products to HCP customers.
Occupation : Medical Professional
Specialty : Other Health Professionals
Country : United States of America
Website :

HEALTH A TO Z